Literature DB >> 23944711

Clinical and genetic features of 5 Chinese patients with X-linked lymphoproliferative syndrome.

J Sun1, W Ying, D Liu, X Hui, Y Yu, J Wang, X Wang.   

Abstract

In this study, we report the clinical and genetic features of Chinese patients with X-linked lymphoproliferative syndrome (XLP). Male patients with fulminant infectious mononucleosis (FIM), Epstein-Barr virus (EBV)-associated hemophagocytic lymphohistiocytosis (HLH) or persistent EBV viremia were enrolled in this study. Direct sequencing was used to detect SH2D1A/XIAP gene mutations. The patients' clinical features were assessed by retrieval of data from medical records. Twenty-one male patients with FIM, EBV-associated HLH or persistent EBV viremia were evaluated. Four patients had SH2D1A mutations, and one patient had an XIAP mutation. All five of these patients had symptoms of HLH and EBV infection. Among the five patients, the youngest one was only 1 month old at onset. One patient exhibited hypogammaglobulinemia. Of four patients evaluated for immunological function, all exhibited reduced CD4/CD8 ratios. Three patients had rapid disease progression and died. One patient received haematopoietic stem cell transplantation and is well. The overall clinical phenotypes of Chinese patients with XLP matched previous reports. For patients with severe EBV-associated HLH, our results indicate the need to examine the possibility of XLP.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23944711     DOI: 10.1111/sji.12103

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  7 in total

1.  Novel Heterogeneous Mutation of TNFAIP3 in a Chinese Patient with Behçet-Like Phenotype and Persistent EBV Viremia.

Authors:  Xiaolong Dong; Luyao Liu; Ying Wang; Xiaotao Yang; Wenjie Wang; Li Lin; Bijun Sun; Jia Hou; Wenjing Ying; Xiaoying Hui; Qinhua Zhou; Danru Liu; Haili Yao; Jinqiao Sun; Xiaochuan Wang
Journal:  J Clin Immunol       Date:  2019-02-27       Impact factor: 8.317

2.  Report of a Chinese Cohort with Activated Phosphoinositide 3-Kinase δ Syndrome.

Authors:  Ying Wang; Wenjie Wang; Luyao Liu; Jia Hou; Wenjing Ying; Xiaoying Hui; Qinhua Zhou; Danru Liu; Haili Yao; Jinqiao Sun; Xiaochuan Wang
Journal:  J Clin Immunol       Date:  2018-11-29       Impact factor: 8.542

3.  Targeted sequencing identifies a novel SH2D1A pathogenic variant in a Chinese family: Carrier screening and prenatal genetic testing.

Authors:  Jun-Yu Zhang; Song-Chang Chen; Yi-Yao Chen; Shu-Yuan Li; Lan-Lan Zhang; Ying-Hua Shen; Chun-Xin Chang; Yu-Qian Xiang; He-Feng Huang; Chen-Ming Xu
Journal:  PLoS One       Date:  2017-02-23       Impact factor: 3.240

4.  Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation.

Authors:  Wenjie Wang; Luyao Liu; Xiaoying Hui; Ying Wang; Wenjing Ying; Qinhua Zhou; Jia Hou; Mi Yang; Bijun Sun; Jinqiao Sun; Xiaochuan Wang
Journal:  BMC Immunol       Date:  2021-03-17       Impact factor: 3.615

Review 5.  Evolution of Our Understanding of XIAP Deficiency.

Authors:  Anne C A Mudde; Claire Booth; Rebecca A Marsh
Journal:  Front Pediatr       Date:  2021-06-17       Impact factor: 3.418

6.  Epstein-Barr virus induced hemophagocytic lymphohistiocytosis in X-linked lymphoproliferative disease.

Authors:  Senthilkumar Sankararaman; Rosario Maria Riel-Romero; Majed Jeroudi; Eduardo Gonzalez-Toledo
Journal:  J Neurosci Rural Pract       Date:  2014-04

7.  X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic.

Authors:  Tao Xu; Qin Zhao; Wenyan Li; Xuemei Chen; Xiuhong Xue; Zhi Chen; Xiao Du; Xiaoming Bai; Qian Zhao; Lina Zhou; Xuemei Tang; Xi Yang; Hirokazu Kanegane; Xiaodong Zhao
Journal:  Eur J Pediatr       Date:  2019-11-21       Impact factor: 3.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.